NVIDIA Inception program startups are leveraging AI to bridge gaps in breast cancer diagnosis and treatment, covering screening, risk assessment, and treatment planning.
NVIDIA's official blog post highlights that startups in its Inception program are leveraging AI to address multiple challenges in breast cancer diagnosis and treatment in the U.S. Among them, iSono Health has developed an FDA-cleared wearable 3D ultrasound system that uses AI to automate image acquisition, improving screening efficiency and accuracy. Whiterabbit.ai's FDA-cleared software, WRDensity, automatically assesses breast density and is developing AI technology to assist radiologists in cancer detection. Ataraxis AI builds clinical intelligence by analyzing pathology slides to predict patient responses to different therapies, aiming for personalized treatment.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Taiwan Capitalization Weighted Stock Index fell 3.31% from the previous close, currently trading at 38,864.60.
-
2
Hang Seng Index fell 1.52% from its previous close, currently trading at 22,941.09
-
3
CRO (Cronos) Price Pulls Back to $0.04135, Hitting Nearly 365-Day Low
-
4
The Taiwan Capitalization Weighted Stock Index (TAIEX) fell 3.81% from its previous close, currently standing at 38,665.32.
-
5
The Shanghai Composite Index fell 1.05% from its previous close, currently trading at 3,550.32.
-
6
Bloomberg: A-Cap's flagship life insurer seeks to defer policyholder payments while exploring sale
-
7
What is PESA coin? Where to trade and buy PESA coin?
-
8
CoinDesk: Nasdaq futures up nearly 2%; Anthropic indicative quotes briefly 24% higher
-
9
Financial Times: Anthropic Discloses Activation of Measures Under 'Responsible Scaling Policy'
-
10
Bloomberg: Anthropic IPO Benefits SK Telecom's Early Investment, Reports Estimate Returns Around $3 Billion
Markets Today
Recommended Reading



